Literature DB >> 12192412

A bacteriolytic agent that detects and kills Bacillus anthracis.

Raymond Schuch1, Daniel Nelson, Vincent A Fischetti.   

Abstract

The dormant and durable spore form of Bacillus anthracis is an ideal biological weapon of mass destruction. Once inhaled, spores are transported by alveolar macrophages to lymph nodes surrounding the lungs, where they germinate; subsequent vegetative expansion causes an overwhelming flood of bacteria and toxins into the blood, killing up to 99% of untreated victims. Natural and genetically engineered antibiotic-resistant bacilli amplify the threat of spores being used as weapons, and heighten the need for improved treatments and spore-detection methods after an intentional release. We exploited the inherent binding specificity and lytic action of bacteriophage enzymes called lysins for the rapid detection and killing of B. anthracis. Here we show that the PlyG lysin, isolated from the gamma phage of B. anthracis, specifically kills B. anthracis isolates and other members of the B. anthracis 'cluster' of bacilli in vitro and in vivo. Both vegetative cells and germinating spores are susceptible. The lytic specificity of PlyG was also exploited as part of a rapid method for the identification of B. anthracis. We conclude that PlyG is a tool for the treatment and detection of B. anthracis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12192412     DOI: 10.1038/nature01026

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  219 in total

Review 1.  Bacteriophage endolysins: a novel anti-infective to control Gram-positive pathogens.

Authors:  Vincent A Fischetti
Journal:  Int J Med Microbiol       Date:  2010-05-10       Impact factor: 3.473

2.  Genomic sequence of C1, the first streptococcal phage.

Authors:  Daniel Nelson; Raymond Schuch; Shiwei Zhu; Donna M Tscherne; Vincent A Fischetti
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

3.  The structure of a family GH25 lysozyme from Aspergillus fumigatus.

Authors:  Justyna E Korczynska; Steffen Danielsen; Ulrika Schagerlöf; Johan P Turkenburg; Gideon J Davies; Keith S Wilson; Edward J Taylor
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-08-21

4.  Staphylococcus aureus virulence attenuation and immune clearance mediated by a phage lysin-derived protein.

Authors:  Hang Yang; Jingjing Xu; Wuyou Li; Shujuan Wang; Junhua Li; Junping Yu; Yuhong Li; Hongping Wei
Journal:  EMBO J       Date:  2018-07-23       Impact factor: 11.598

5.  Characterization of Salmonella bacteriophages isolated from swine lagoon effluent.

Authors:  Michael R McLaughlin; Rodney A King
Journal:  Curr Microbiol       Date:  2007-11-10       Impact factor: 2.188

Review 6.  Bacteriophage endolysins as novel antimicrobials.

Authors:  Mathias Schmelcher; David M Donovan; Martin J Loessner
Journal:  Future Microbiol       Date:  2012-10       Impact factor: 3.165

7.  The tubulin-like RepX protein encoded by the pXO1 plasmid forms polymers in vivo in Bacillus anthracis.

Authors:  Parvez Akhtar; Syam P Anand; Simon C Watkins; Saleem A Khan
Journal:  J Bacteriol       Date:  2009-02-20       Impact factor: 3.490

8.  Detailed genomic analysis of the Wbeta and gamma phages infecting Bacillus anthracis: implications for evolution of environmental fitness and antibiotic resistance.

Authors:  Raymond Schuch; Vincent A Fischetti
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

9.  A novel FtsZ-like protein is involved in replication of the anthrax toxin-encoding pXO1 plasmid in Bacillus anthracis.

Authors:  Eowyn Tinsley; Saleem A Khan
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

10.  Characterization of LytA-like N-acetylmuramoyl-L-alanine amidases from two new Streptococcus mitis bacteriophages provides insights into the properties of the major pneumococcal autolysin.

Authors:  Patricia Romero; Rubens López; Ernesto García
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.